Thomas J. Schuetz, CHIEF EXECUTIVE OFFICER at Compass Therapeutics, Inc. (CMPX), bought 10,000 shares at $2.11 ($21K) on 2025-05-27, disclosed to the SEC on 2025-05-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CMPX | BUY | 2023-02-15 | $77K | — | Filing → |
| CMPX | BUY | 2023-01-31 | $81K | — | Filing → |
| CMPX | BUY | 2023-01-24 | $168K | — | Filing → |